Inhibition of Radiographic Progression With Bimekizumab Treatment Observed in bDMARD- Na&#239;ve Patients With Active Psoriatic Arthritis at 2 Years: Results From a Phase 3 Study and Its Open- Label Extension

Bimzelx (bimekizumab-bkzx) - UCB

Humira (adalimumab) - AbbVie

https://static1.squarespace.com/static/6642bbced8b22f3bcd7949a5/t/6a05b7ce0e0e4a17617431e0/1778759630269/APL_v29_iS2_Rev4.pdf

Peter Nash1; Laura C. Coates2; M. Elaine Husni3; Mitsumasa Kishimoto4; Proton Rahman5; Philipp Sewerin6; Enrique R. Soriano7; Barbara Ink8; Rajan Bajracharya8; Jason Coarse9; Philip J. Mease10

May 26, 2026